VAERS reports by lot

Novartis Vaccines Meningococcal lot 5AR2D: VAERS reports

29 VAERS reports list lot 5AR2D as a Novartis Vaccines Meningococcal vaccine, received between 2023-04-07 and 2023-11-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2227%
Cardiac / Cardiovascular2126%
Injection-site / Local reaction1316%
Neurological67%
Thrombotic / Hematological67%
Musculoskeletal56%
Gastrointestinal34%
Allergic / Anaphylactic22%
Dermatological (non-injection-site)22%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Washington3
New York3
Pennsylvania2
Texas2
Illinois2
Rhode Island1
Puerto Rico1
California1
Virginia1
Oregon1
Kansas1

Reports by month received

2023-041
2023-053
2023-063
2023-073
2023-0810
2023-095
2023-103
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.